Liver Injury and Its Impact on Prognosis in Patients with HBV-Related Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors.

Authors:
Shen J; Wang X; Yang G; Li L; Fu J and 3 more

Journal:
J Hepatocell Carcinoma

Publication Year: 2024

DOI:
10.2147/JHC.S431191

PMCID:
PMC10822136

PMID:
38283694

Journal Information

Full Title: J Hepatocell Carcinoma

Abbreviation: J Hepatocell Carcinoma

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure Jiaming Shen, Xia Wang and Guangde Yang are co-first authors of this study. The authors report no conflicts of interest related to this work."

Evidence found in paper:

"There is no funding to report."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025